1Lamm D L. Prohylaxis for recurrent transitional cell carcinoma urology[J]. Urology, 1991,37 : 21-23. 被引量：1
2McCabe R P, Lamm L D, Hascel M V, et al. A diagnostic-prognostic test for bladder cancer using a monoclonal antibodybased enzymelinked imunoasay for detection of urinary fibrin ogen degradation products[J]. Cancer Res, 1984,44 : 5886. 被引量：1
1Kaisary AV.Intravesical BCG therapy in the management of multiple superficial bladder carcinoma:comparison between glaxo and pasteur strains.Br J Urol ,1987,59:554-558. 被引量：1
2Jurincic CD,Engelmann U,Gasch J,et al.Immunotherapy in bladder cancer with keyholelimpet hemocyamia;a randomized study.J Urol,1988,139:723-736. 被引量：1
3Brosman SA.Experience with superficial bladder carcinoma.J Urol,1982,128:27-30. 被引量：1
4Popert RJM,Goodall J,Coptcoat MJ,et al.Superficial bladder cancer:the response of a marker tumour to a single intravesical instillation of epirubicin.Br J Urol,1994,66:195-199. 被引量：1
5Oosterlinch W,Kurth KH,Schroder F,et al.A prospective European organization for research and treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single instillation of epirubicin or eater in single stage Ta,Ti papillary carcinoma of the bladder.J Urol,1993,149:749-752. 被引量：1
